U.S. Markets closed

Analysis: Positioning to Benefit within EMCOR Group, Ring Energy, A. O. Smith, bluebird bio, Ligand Pharmaceuticals, and Synovus Financial — Research Highlights Growth, Revenue, and Consolidated Results

NEW YORK, June 28, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of EMCOR Group, Inc. (EME), Ring Energy, Inc. (REI), A. O. Smith Corporation (AOS), bluebird bio, Inc. (BLUE), Ligand Pharmaceuticals Incorporated (LGND), and Synovus Financial Corp. (SNV), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

EME DOWNLOAD: http://Fundamental-Markets.com/register/?so=EME
REI DOWNLOAD:
http://Fundamental-Markets.com/register/?so=REI
AOS DOWNLOAD:
http://Fundamental-Markets.com/register/?so=AOS
BLUE DOWNLOAD:
http://Fundamental-Markets.com/register/?so=BLUE
LGND DOWNLOAD:
http://Fundamental-Markets.com/register/?so=LGND
SNV DOWNLOAD:
http://Fundamental-Markets.com/register/?so=SNV

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine EMCOR Group, Inc. (EME), Ring Energy, Inc. (REI), A. O. Smith Corporation (AOS), bluebird bio, Inc. (BLUE), Ligand Pharmaceuticals Incorporated (LGND), and Synovus Financial Corp. (SNV) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed June 26th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

EMCOR GROUP, INC. (EME) REPORT OVERVIEW

EMCOR Group's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, EMCOR Group reported revenue of $1,900.39MM vs $1,891.73MM (up 0.46%) and basic earnings per share $0.95 vs $0.88 (up 7.95%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, EMCOR Group reported revenue of $7,687.00MM vs $7,551.52MM (up 1.79%) and basic earnings per share $3.84 vs $3.00 (up 28.00%). EMCOR Group is expected to report earnings on July 26th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.95. The estimated EPS forecast for the next fiscal year is $4.91 and is expected to report on February 28th, 2019.

To read the full EMCOR Group, Inc. (EME) report, download it here: http://Fundamental-Markets.com/register/?so=EME

-----------------------------------------

RING ENERGY, INC. (REI) REPORT OVERVIEW

Ring Energy's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Ring Energy reported revenue of $29.89MM vs $12.24MM (up 144.13%) and basic earnings per share $0.10 vs $0.03 (up 233.33%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Ring Energy reported revenue of $66.70MM vs $30.85MM (up 116.20%) and basic earnings per share $0.03 vs -$0.97. Ring Energy is expected to report earnings on August 14th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.04. The estimated EPS forecast for the next fiscal year is $1.17 and is expected to report on March 21st, 2019.

To read the full Ring Energy, Inc. (REI) report, download it here: http://Fundamental-Markets.com/register/?so=REI

-----------------------------------------

A. O. SMITH CORPORATION (AOS) REPORT OVERVIEW

A. O. Smith's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, A. O. Smith reported revenue of $788.00MM vs $740.00MM (up 6.49%) and basic earnings per share $0.58 vs $0.51 (up 13.73%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, A. O. Smith reported revenue of $2,996.70MM vs $2,685.90MM (up 11.57%) and basic earnings per share $1.72 vs $1.87 (down 8.02%). A. O. Smith is expected to report earnings on July 25th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.53. The estimated EPS forecast for the next fiscal year is $2.92 and is expected to report on January 29th, 2019.

To read the full A. O. Smith Corporation (AOS) report, download it here: http://Fundamental-Markets.com/register/?so=AOS

-----------------------------------------

BLUEBIRD BIO, INC. (BLUE) REPORT OVERVIEW

bluebird bio's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, bluebird bio reported revenue of $15.96MM vs $6.83MM (up 133.56%) and basic earnings per share -$2.31 vs -$1.68. For the twelve months ended December 31st, 2017 vs December 31st, 2016, bluebird bio reported revenue of $35.43MM vs $6.16MM (up 475.58%) and basic earnings per share -$7.71 vs -$7.07. bluebird bio is expected to report earnings on August 1st, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$1.73. The estimated EPS forecast for the next fiscal year is -$9.46 and is expected to report on February 20th, 2019.

To read the full bluebird bio, Inc. (BLUE) report, download it here: http://Fundamental-Markets.com/register/?so=BLUE

-----------------------------------------

LIGAND PHARMACEUTICALS INCORPORATED (LGND) REPORT OVERVIEW

Ligand Pharmaceuticals' Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Ligand Pharmaceuticals reported revenue of $56.16MM vs $29.27MM (up 91.88%) and basic earnings per share $2.13 vs $0.24 (up 787.50%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Ligand Pharmaceuticals reported revenue of $141.10MM vs $108.97MM (up 29.48%) and basic earnings per share $0.60 vs -$0.08. Ligand Pharmaceuticals is expected to report earnings on August 6th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.54. The estimated EPS forecast for the next fiscal year is $5.29 and is expected to report on February 20th, 2019.

To read the full Ligand Pharmaceuticals Incorporated (LGND) report, download it here: http://Fundamental-Markets.com/register/?so=LGND

-----------------------------------------

SYNOVUS FINANCIAL CORP. (SNV) REPORT OVERVIEW

Synovus Financial's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Synovus Financial reported interest income of $313.13MM vs $272.40MM (up 14.95%) and basic earnings per share $0.85 vs $0.57 (up 49.12%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Synovus Financial reported interest income of $1,162.50MM vs $1,022.80MM (up 13.66%) and basic earnings per share $2.19 vs $1.90 (up 15.26%). Synovus Financial is expected to report earnings on July 17th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.60. The estimated EPS forecast for the next fiscal year is $3.96 and is expected to report on January 22nd, 2019.

To read the full Synovus Financial Corp. (SNV) report, download it here: http://Fundamental-Markets.com/register/?so=SNV

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.